DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining...

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Genomic instability from DNA repair defects increases tumor immunogenicity.
• Inhibiting DNA damage response (DDR) can enhance anti-tumor immunity.
• The precise mechanisms linking DDR and immune signaling are not fully understood.

Purpose of the Study:

• To review how DDR deficiency impacts anti-tumor immunity.
• To highlight the cGAS-STING axis as a key mediator.
• To summarize clinical trials combining DDR inhibition and immunotherapy.

Main Methods:

• Literature review of DNA repair, genomic instability, and cancer immunotherapy.
• Analysis of studies on the cGAS-STING pathway in cancer.
• Review of ongoing and completed clinical trials.

Main Results:

• DDR deficiency can promote an anti-tumor immune response.
• The cGAS-STING pathway is a critical link between DDR and immune activation.
• Clinical trials show promise in combining DDR inhibitors with immunotherapies.

Conclusions:

• Understanding the DDR-immune interplay is crucial for cancer treatment.
• Targeting DDR pathways offers a novel strategy to enhance cancer immunotherapy.
• Further research and clinical trials are needed to optimize combination therapies.